Skip to main content

Table 3 Reported treatment for cardiovascular risk factors

From: Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study

CV risk factor Treatment Responders with reported risk factor reporting receiving treatment p
  RA PsA  
  N (%) N (%)  
Hypertension Pharmacological 259/279 (92.8) 50/53 (94.3) 0.7
Diabetes Diet and/or pharmacological 73/73 (100.0) 14/14 (100.0) N/A
Hyperlipidaemia Pharmacological 109/157 (69.4) 19/26 (73.1) 0.7
Overweight or obese Any dietary change in the last year 151/564 (26.8) 36/131 (27.5) 0.9
Commercial weight loss program 21/564 (3.7) 3/131 (2.3) 0.4
Health professional weight loss program 44/564 (7.8) 7/131 (5.3) 0.3
Meal replacements 53/564 (9.4) 10/131 (7.6) 0.5
Exercise program 57/564 (10.1) 11/131 (8.4) 0.6
Bariatric surgery 4/564 (0.7) 1/131 (0.8) 0.9
  1. Treatment for hypertension, diabetes, hyperlipidaemia and being overweight or obese in RA and PsA respondents to the Heart Survey and a comparison of the two disease groups
  2. CV cardiovascular, RA rheumatoid arthritis, PsA psoriatic arthritis, N/A not applicable